World AIDs Day is a global event marked on the 1st of December each year. The occasion is held in support of People Living with HIV/AIDs, to commemorate those who have passed on due to HIV/AIDs related causes as well as celebrating the success and advancements made in the last decades in the prevention/management of HIV.
Newly emerging pathogens including bacterial pathogens with emerging resistance to current antimicrobial agents pose a major public health problem globally. There is an urgent need for more trans-disciplinary and trans-sectorial approaches to prioritize and tackle this emerging public health problem.
On 24th September 2019, the first volunteer was enrolled in the IAVI-W001 study at the KAVI-Institute of Clinical Research (KAVI-ICR) of the University of Nairobi. The occasion marks the beginning of the 12th HIV vaccine clinical trial to be conducted at KAVI-ICR since 2001. This is a first-in-human study that uses a Native-trimer HIV envelope design that will hopefully stimulate broadly neutralizing antibodies against HIV.